Aripiprazole in schizophrenia: consensus guidelines.

Journal article

Schizophrenia is a chronic disabling disease which in the majority of cases requires long-term treatment with antipsychotic medication. Before the development of atypical antipsychotics, treatment choice was restricted to conventional (or typical) antipsychotics, which are known to cause a range of side effects including extrapyramidal symptoms. Although atypical agents provide a favourable alternative (advocated by the National Institute of Clinical Excellence in the UK), they are associated...

Expand abstract

Authors: Travis, M; Burns, T; Dursun, S; Fahy, T; Frangou, S

• Publication status: Published
• Journal: International journal of clinical practice
• Volume: 59
• Issue: 4
• Pages: 485-495
• Publication date: 2005-04-01
• DOI: 10.1111/j.1368-5031.2005.00498.x
• EISSN: 1742-1241
• ISSN: 1368-5031
• Language: English
• Keywords: Drug Interactions; Schizophrenia; Heart Diseases; Hypertension; Metabolic Diseases; Consensus; Piperazines; Treatment Outcome; Mental Disorders; Quinolones; Antipsychotic Agents; Patient Compliance; Humans